GCEA Value Flower: Summary and A Path Forward

Meng Li (2024) has a nice summary of the generalized cost effectiveness analysis (GCEA) user guide paper (see Shafrin et al. 2024) that was published last month. The GCEA methodology encompasses 15 ‘petals’ across four domains. The uncertainty domain captures how risk aversion and uncertainty in treatment outcomes impact value, including aspects such as outcome…

Read More

La administración Trump investiga el gasto de estados demócratas en Medicaid para inmigrantes

SACRAMENTO, California — La administración Trump ha extendido su política de mano dura en inmigración a la red de atención médica pública, iniciando investigaciones sobre el gasto de Medicaid en al menos seis estados liderados por demócratas. Estos estados brindan cobertura médica integral a inmigrantes pobres y con discapacidades que viven en el país sin…

Read More

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center. The post Healthcare…

Read More

Beam’s Base-Editing Sickle Cell Therapy Shows Early Promise, But a Fatality Overshadows Results

The death wasn’t due to Beam Therapeutics’ sickle cell disease therapy, BEAM-101, but was instead attributed to the preconditioning treatment needed before the genetic medicine is infused. A different Beam program in preclinical development could avoid the need for toxic preconditioning; data from both programs will be presented during the upcoming American Society of Hematology…

Read More